Cite
APA Citation
Mody, R., Huang, Q., Yu, M., Zhao, R., Patel, H., Grabner, M., & Landó, L. F. (2019). adherence, persistence, glycaemic control and costs among patients with type 2 diabetes initiating dulaglutide compared with liraglutide or exenatide once weekly at 12‐month follow‐up in a real‐world setting in the United States. Diabetes, obesity & metabolism, 21(4), 920–929. http://access.bl.uk/ark:/81055/vdc_100078578953.0x000019